Consumer health company’s shares open at 330p, giving it a market value of about £31bn
GSK’s consumer spin-off Haleon, home to brands from Sensodyne toothpaste to Panadol painkillers, has begun trading on the London Stock Exchange in the biggest European listing in a decade.
Haleon shares started trading on Monday morning at 330p, with a market value of about £31bn.
